Elevated serum levels of APRIL, a B-cell-activating factor of the tumor necrosis factor family (BAFF) homolog, was associated with higher incidence of pulmonary fibrosis in a population of patients with systemic sclerosis [31]. This evidence concerns the gene TNFSF13B and pulmonary fibrosis.